PhaseBio Pharmaceuticals Alpha and Beta Analysis
| PHASQDelisted Stock | USD 0.0003 0.0001 25.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as PhaseBio Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in PhaseBio Pharmaceuticals over a specified time horizon. Remember, high PhaseBio Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to PhaseBio Pharmaceuticals' market risk premium analysis include:
Beta 95 | Alpha 190.75 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
PhaseBio |
PhaseBio Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. PhaseBio Pharmaceuticals market risk premium is the additional return an investor will receive from holding PhaseBio Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in PhaseBio Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate PhaseBio Pharmaceuticals' performance over market.| α | 190.75 | β | 95.00 |
PhaseBio Pharmaceuticals Fundamentals Vs Peers
Comparing PhaseBio Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze PhaseBio Pharmaceuticals' direct or indirect competition across all of the common fundamentals between PhaseBio Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as PhaseBio Pharmaceuticals or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of PhaseBio Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing PhaseBio Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare PhaseBio Pharmaceuticals to competition |
| Fundamentals | PhaseBio Pharmaceuticals | Peer Average |
| Return On Asset | -1.06 | -0.14 |
| Operating Margin | (127.39) % | (5.51) % |
| Current Valuation | (1.26 M) | 16.62 B |
| Shares Outstanding | 49.86 M | 571.82 M |
| Shares Owned By Insiders | 6.72 % | 10.09 % |
| Shares Owned By Institutions | 25.02 % | 39.21 % |
| Number Of Shares Shorted | 2.07 M | 4.71 M |
PhaseBio Pharmaceuticals Opportunities
PhaseBio Pharmaceuticals Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About PhaseBio Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including PhaseBio or other pink sheets. Alpha measures the amount that position in PhaseBio Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PhaseBio Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PhaseBio Pharmaceuticals' short interest history, or implied volatility extrapolated from PhaseBio Pharmaceuticals options trading.
Build Portfolio with PhaseBio Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in PhaseBio Pink Sheet
If you are still planning to invest in PhaseBio Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PhaseBio Pharmaceuticals' history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |